Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
14 14 Search
2023
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
World Journal of Gastroenterology
2023
Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers
Current Microbiology
2022
Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy
Frontiers in Immunology
2022
Significance of anti‐HBc serological status in primary immune thrombocytopenia
British Journal of Haematology
2022
A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
Frontiers in Immunology
2021
Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
European Journal of Gastroenterology & Hepatology
2021
Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
BMJ Case Reports
2021
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
2021
Serial changes in FIB‐4 score and hepatocarcinogenesis in hepatitis B patients treated with or without nucleot(s)ide analogue therapy
GastroHep
2021
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
Journal of Personalized Medicine
2020
Serological hepatitis B virus (HBV) activity in patients with HBV infection and B‐cell non‐Hodgkin’s lymphoma
European Journal of Haematology
2020
Rituximab-induced autoimmune hepatitis: A case study and literature review
Canadian Liver Journal
2020
Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues
Journal of Viral Hepatitis
2020
Antineoplastics
Reactions Weekly